ERBB2 and breast neoplasm: Following transgene deinduction, all primary and metastatic breast tumors regressed, suggesting that, although several genetic and epigenetic events occur during HER2-induced mammary tumorigenesis, most cells remain dependent upon HER2 for the maintenance of the malignant state.